{"doi":"10.1016/j.jpha.2024.101001","title":"Clinically and orally compatible formulation-manufactured DDX5 (p68)-targeting molecular glue FL118 products exhibit low toxicity but high efficacy against human cancer","abstract":"• FL118 drug substances (DS) exhibited high chemical stability under various test conditions and showed no effect on purity/impurity changes. • Clinically and orally compatible FL118 drug products (DP) were obtained via formulation of FL118 DS with 2-hydroxypropyl-β-cyclodextrin (HPβCD) using mixed glacial acetic acid (GAA) with ethanol (10:90), followed by microfluidizer-mediated spray dried dispersion (M-SDD). • Toxicology studies in rats and dogs indicated that the clinically and orally compatible FL118 DP exhibit much lower toxicity with doubled maximum tolerated dose (MTD) than those from the preclinically/non-clinically compatible FL118 DP. • The clinically and orally compatible FL118 DP exhibited exceptional efficacy against human colorectal cancer, pediatric osteosarcoma, castration-resistant prostate cancer and pancreatic cancer.","journal":"Journal of Pharmaceutical Analysis","year":2024,"id":444646,"datarank":0.31191623125197543,"base_score":2.0794415416798357,"endowment":2.0794415416798357,"self_citation_contribution":0.31191623125197543,"citation_network_contribution":0.0,"self_endowment_contribution":0.31191623125197543,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":7,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9515,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2024-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":570311,"name":"Wenjie Wu","orcid":"0000-0002-0907-0561","position":1,"is_corresponding":false},{"id":243275,"name":"Li Yan","orcid":"0000-0002-4792-9998","position":2,"is_corresponding":false},{"id":532733,"name":"Leslie Curtin","orcid":null,"position":3,"is_corresponding":false},{"id":1260554,"name":"Melanie M. Farrauto","orcid":null,"position":4,"is_corresponding":false},{"id":531693,"name":"Sandra Sexton","orcid":"0000-0001-8960-1133","position":5,"is_corresponding":false},{"id":630324,"name":"Anmbreen Jamroze","orcid":"0009-0006-0444-820X","position":6,"is_corresponding":false},{"id":927494,"name":"Changjun Yu","orcid":"0000-0002-3975-4040","position":7,"is_corresponding":false},{"id":364196,"name":"Christos Fountzilas","orcid":"0000-0003-3837-5644","position":8,"is_corresponding":false},{"id":263780,"name":"Dean G. Tang","orcid":"0000-0001-5029-1174","position":9,"is_corresponding":false},{"id":364198,"name":"Fengzhi Li","orcid":"0000-0002-2299-7951","position":10,"is_corresponding":false},{"id":364192,"name":"Xiang Ling","orcid":"0009-0004-1587-8315","position":0,"is_corresponding":true}],"reference_count":6,"raw_metadata":{"citation_network_status":"fetched"},"created_at":"2026-07-19T02:01:37.886033Z","pmid":"39759975","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}